LAG3 and neoplasm: Increased hepatic tumor load and intrinsic tumor factors such as low tumor mutational burden, PD1/PDL1 expression levels, and increased presence of alternative immunosuppressive molecules like Lymphocyte-activation gene-3 (LAG3) in mUM compared to mCM may explain such inefficacy (52–55).